Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Bioreactors Market Will Reach USD 2154.4 Million By 2028 With A CAGR of 6.0% - Valuates Reports

      This image opens in the lightbox

      News provided by

      Valuates Reports

      05 May, 2022, 13:30 GMT

      Share this article

      Share this article


      BANGALORE, India, May 5, 2022 /PRNewswire/ -- Bioreactors market is Segmented by Type - Disposable, Reusable, by Application - Research and Development, Biopharmaceutical, Others. Global Opportunity Analysis and Industry Forecast 2022 - 2028. It is published in Valuates Reports under the Medical Devices & Equipment Category.

      Bioreactors market size is estimated to be worth USD 1523.1 million in 2022 and is forecast to be a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.

      Major factors driving the growth of the bioreactors market are

      The bioreactors market is growing due to increased funding from private and government organizations for vaccine research and development, as well as increased demand from the biopharmaceutical industry and monoclonal antibiotics.

      Furthermore, the number of clinical and pre-clinical trial studies is increasing, which is driving the bioreactors market forward.

      Browse The Table of Contents And List of Figures At https://reports.valuates.com/reports/QYRE-Auto-16C2870/covid-19-impact-on-global-bioreactors

      TRENDS INFLUENCING THE GROWTH OF BIOREACTORS MARKET 

      The bioreactors market is expected to grow due to the increasing use of bioreactors in various R&D projects. In the development and production of engineered biological products, bioreactors are essential. They mimic the in vivo microenvironment of tissue growth while also providing various mechanical and biochemical signals to stem cells in order to successfully generate transplantable organs or tissues.

      Biopharmaceutical manufacturing, which includes enzymes, vaccines, antibodies, growth factors, and hormones, is a difficult task in which small differences in manufacturing conditions can have a significant impact on product quality, efficacy, safety, and yield. Because the majority of commercial biopharmaceutical proteins are complex glycoproteins, they must be manufactured under strict conditions. Bioreactors aid in the production of biopharmaceuticals under controlled and repeatable conditions, all while adhering to GMP guidelines. This factor is expected to further drive the growth of the bioreactors market.

      The market value will be boosted by rising bioreactor demand for clinical studies and biopharma manufacturers' focus on innovation. The demand for small-scale bioreactors has grown as the number of pre-clinical and clinical-stage studies in the development of various therapeutic drugs for rare and chronic diseases has increased. The bioreactors market revenue is also boosted by pharmaceutical manufacturers' continued focus on product innovation and increased R&D expenditure. 

      COVID-19 has sparked a significant increase in demand for preventive vaccines and effective treatment therapeutics. Several pharmaceutical companies have increased their production capacities in order to meet rising drug demand, boosting bioreactor sales during the pandemic. Additionally, increased vaccine development R&D activities around the world have created the potential for clinical-stage bioreactors. This in turn is expected to drive the growth of the bioreactors market.

      Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-16C2870/Global_Bioreactors_Market

      BIOREACTORS MARKET SHARE ANALYSIS

      Based on type, The single-use bioreactor is expected to be the most lucrative segment. Single-use bioreactor systems have become widely accepted in today's biopharmaceutical manufacturing methods that prioritize high product yield. Single-use bioreactors' flexibility, cost-effectiveness, and high mass production will increase demand, thereby affecting growth.

      Based on application, Research and development are expected to be the most lucrative segment. 

      Based on region, Asia-Pacific is expected to be the most lucrative region. Asian companies, including domestic players and international giants, are estimated to be building about half of all new bioprocessing facilities around the world. In the near future, this is expected to be a major driving force in the Asia Pacific market. Because of its high adoption of single-use technology, China is expected to be at the forefront. 

      Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-16C2870/Global_Bioreactors_Market

      Market By Region

      • North America
      • Europe
      • Asia-Pacific
      • Latin America
      • Middle East & Africa

      Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-16C2870/Global_Bioreactors_Market

      Key players

      • PBS Biotech
      • Eppendorf
      • Kühner
      • TAP Biosystems
      • Sartorius
      • Celltainer
      • Pall(Danaher)
      • Merck Millipore
      • Eppendorf
      • 2mag AG
      • Finesse
      • Sartorius
      • Thermo Fisher
      • Amprotein
      • Applikon
      • GE Healthcare
      • SYNTHECON
      • Solaris

      Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-16C2870/Global_Bioreactors_Market

      Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-16C2870&lic=single-userv

      SUBSCRIPTION

      We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

      SIMILAR REPORTS

      -  The global Parallel Bioreactors market was valued at USD 283.6 million in 2020 and it is expected to reach USD 574 million by the end of 2027, growing at a CAGR of 10.6% during 2021-2027.

      -  Micro Bioreactors market size is estimated to be worth USD 147 million in 2022 and is forecast to a readjusted size of USD 246.5 million by 2028 with a CAGR of 9.0% during the review period.

      -  Perfusion Bioreactors market size is estimated to be worth USD 745.3 million in 2022 and is forecast to a readjusted size of USD 1257.5 million by 2028 with a CAGR of 9.1% during the review period.

      -  The global Single-use Bioprocessing market size is projected to reach USD 6956.3 million by 2027, from USD 3905.3 million in 2020, at a CAGR of 10.1% during 2021-2027.

      -  The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

      -  The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

      -  Global Bioreactors and Fermenters Market Insights and Forecast to 2028

      -  Global Packed Bed Bioreactors Market Research Report 2022

      -  Global Cell Culture Bioreactors Market Insights, Forecast to 2028

      -  Global Portable Bioprocessing Bioreactors Market Insights and Forecast to 2028

      -  Global and United States Industrial Bioreactors Market Insights, Forecast to 2027

      -  Global Hollow Fiber Bioreactors Market Insights and Forecast to 2028

      -  Global Disposable Bioreactors Market Insights and Forecast to 2028

      Click Here To See Related Reports on Bioreactors Market

      About Us:

      Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

      Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

      To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

      Contact Us:

      Valuates Reports
      sales@valuates.com
      For U.S. Toll-Free Call 1-(315)-215-3225
      For IST Call +91-8040957137
      WhatsApp: +91-9945648335
      Website: https://reports.valuates.com 
      Twitter - https://twitter.com/valuatesreports

      Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg 

      Modal title

      Also from this source

      Healthcare Training Market to Reach USD 1717 Million by 2031, Driven by E-Learning, Blended Learning, and Clinical Skills Development | Valuates Reports

      Healthcare Training Market to Reach USD 1717 Million by 2031, Driven by E-Learning, Blended Learning, and Clinical Skills Development | Valuates Reports

      What is the Market Size of Healthcare Training? The global Healthcare Training Market was valued at USD 1252 Million in 2024 and is projected to...

      M2M Healthcare Market Size to Reach USD 28.77 Billion by 2031 Driven by Connected Healthcare and Remote Monitoring Adoption | Valuates Reports

      M2M Healthcare Market Size to Reach USD 28.77 Billion by 2031 Driven by Connected Healthcare and Remote Monitoring Adoption | Valuates Reports

      What is the Market Size of M2M Healthcare? According to Valuates Reports, The global market for M2M Healthcare was valued at USD 8438 Million in the...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Biotechnology

      Biotechnology

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.